New Zealand markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
244.35+2.33 (+0.96%)
At close: 04:04PM EST
244.62 +0.27 (+0.11%)
After hours: 07:44PM EST

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-0645
United States
610 594 2900
https://www.westpharma.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees10,065

Key executives

NameTitlePayExercisedYear born
Mr. Eric M. GreenChair, Pres & CEO3.42MN/A1970
Mr. Bernard J. BirkettSr. VP and Chief Financial & Operations Officer1.5MN/A1969
Mr. Silji AbrahamSr. VP & Chief Technology Officer1.11MN/A1972
Ms. Kimberly Banks MacKaySr. VP, Gen. Counsel & Company Sec.946.43kN/A1966
Mr. Chad R. WintersVP, Chief Accounting Officer & Corp. ControllerN/AN/A1979
Dr. Quintin J. Lai C.F.A., Ph.D.VP of Strategy & Investor RelationsN/AN/A1967
Michele PolinskyVP of Global CommunicationsN/AN/AN/A
Mr. Robert SeguraVP of Corp. Devel.N/AN/AN/A
Ms. Annette F. FavoriteChief HR Officer & Sr. VPN/AN/A1965
Mr. Richard D. LuzziSr. VP of HRN/AN/A1952
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Corporate governance

West Pharmaceutical Services, Inc.’s ISS governance QualityScore as of 1 December 2022 is 7. The pillar scores are Audit: 7; Board: 9; Shareholder rights: 7; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.